The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Neuroleptic Malignant Syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Neuroleptic malignant syndrome
Caroff, S. N., & Mann, S. C. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30278-4 · Cited by 514
Self-citationThe neuroleptic malignant syndrome
(1980) · Reactions · doi:10.1007/bf03264026 · Cited by 460
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.10.1227 · Cited by 302
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1374 · Cited by 288
Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs
Ananth, J., Parameswaran, S., Gunatilake, S., Burgoyne, K., & Sidhom, T. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0403 · Cited by 273
Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases
Trollor, J. N., & Sachdev, P. S. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00630.x · Cited by 226
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Gurrera, R. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.169 · Cited by 214
Neuroleptic malignant syndrome. Review of response to therapy
Rosenberg, M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.9.1927 · Cited by 185
Neuroleptic malignant syndrome and catatonia: One entity or two?
Fink, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00552-8 · Cited by 164
Neuroleptic Malignant Syndrome and Related Conditions
(2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000106130.70856.aa · Cited by 163
Serum iron and neuroleptic malignant syndrome
Rosebush, P. I., Mazurek, M. F., & Mazurek, M. F. (1991) · The Lancet · doi:10.1016/0140-6736(91)90138-f · Cited by 131
Serum iron in catatonia and neuroleptic malignant syndrome
Lee, J. W. Y. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00109-7 · Cited by 124
Managing an effective treatment for neuroleptic malignant syndrome
Reulbach, U., Dütsch, C., Biermann, T., Sperling, W., Thuerauf, N., Kornhuber, J., & Bleich, S. (2007) · Critical Care · doi:10.1186/cc5148 · Cited by 117
Severe and Uncommon Involuntary Movement Disorders due to Psychotropic Drugs
Stübner, S., Rustenbeck, E., Grohmann, R., Wagner, G., Engel, R. R., Neundörfer, G., Möller, H., Hippius, H., & Rüther, E. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-815511 · Cited by 116
Central Dopamine Hypoactivity and the Pathogenesis of Neuroleptic Malignant Syndrome
Mann, S. C., Caroff, S. N., Fricchione, G. L., & Campbell, E. C. (2000) · Psychiatric Annals · doi:10.3928/0048-5713-20000501-14 · Cited by 74
Self-citationResidual Catatonic State Following Neuroleptic Malignant Syndrome
Caroff, S. N., Mann, S. C., Keck, P. E., & Francis, A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00021 · Cited by 73
Self-citationIs Lorazepam a Treatment for Neuroleptic Malignant Syndrome?
Francis, A., Chandragiri, S. S., Rizvi, S. Z. H., Koch, M., & Petrides, G. (2000) · CNS Spectrums · doi:10.1017/s1092852900013407 · Cited by 67
A rating scale for neuroleptic malignant syndrome
Sachdev, P. S. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.05.003 · Cited by 58
Neuroleptic malignant syndrome
Caroff, S. N., Mann, S. C., & Campbell, E. C. (2001) · Adverse Drug Reaction Bulletin · doi:10.1097/00012995-200108000-00001 · Cited by 57
Self-citation
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Management of common adverse effects of antipsychotic medications
Stroup, T. S., & Gray, N. (2018) · World Psychiatry · doi:10.1002/wps.20567 · Cited by 572
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Metadata
- Authors
- Strawn, J. R., Keck, P. E., & Caroff, S. N.
- Venue
- American Journal of Psychiatry
- Published
- 2007-06
- Volume
- 164
- Issue
- 6
- Pages
- 870-876
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2125205006
- Cited by
- 579
- References
- 20
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.